Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Long Chuang

Showing results (221-230 of 456) with videos related to

Pageof 46
Sort By:
Gut|September 8, 2006
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensationChia-Yen Dai, Ming-Lung Yu, Ming-Yen Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
The Journal of Infectious Diseases|January 28, 2010
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis CChung-Feng Huang, Jeng-Fu Yang, Chia-Yen Dai, et al.
Antiviral Research|April 3, 2007
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis BChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.
BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 31, 2012
Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinomaKiong-Ming Wong, Ming-Lun Yeh, Shih-Chung Chuang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 3, 2020
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsYasuhiro Asahina, Chun-Jen Liu, Edward Gane, et al.
Pageof 46

Showing results (221-230 of 456) with videos related to

Sort By:
Pageof 46
Gut|September 8, 2006
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis CMing-Lung Yu, Chia-Yen Dai, Jee-Fu Huang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 29, 2007
Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensationChia-Yen Dai, Ming-Lung Yu, Ming-Yen Hsieh, et al.
The Kaohsiung Journal of Medical Sciences|October 21, 2017
The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon-free direct antiviral agentsJee-Fu Huang, Chung-Feng Huang, Ming-Lun Yeh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 23, 2017
25-Hydroxy vitamin D suppresses hepatitis C virus replication and contributes to rapid virological response of treatment efficacyJee-Fu Huang, Yu-Min Ko, Chung-Feng Huang, et al.
The Journal of Infectious Diseases|January 28, 2010
Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis CChung-Feng Huang, Jeng-Fu Yang, Chia-Yen Dai, et al.
Antiviral Research|April 3, 2007
Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis BChia-Yen Dai, Wan-Long Chuang, Ming-Yen Hsieh, et al.
Hepatology Communications|April 13, 2019
Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C InfectionTomi Jun, Yao-Chun Hsu, Shintaro Ogawa, et al.
BMJ Open|May 8, 2019
Equal treatment efficacy of direct-acting antivirals in patients with chronic hepatitis C and hepatocellular carcinoma? A prospective cohort studyChung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|August 31, 2012
Survival comparison between surgical resection and percutaneous radiofrequency ablation for patients in Barcelona Clinic Liver Cancer early stage hepatocellular carcinomaKiong-Ming Wong, Ming-Lun Yeh, Shih-Chung Chuang, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 3, 2020
Twelve weeks of ledipasvir/sofosbuvir all-oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trialsYasuhiro Asahina, Chun-Jen Liu, Edward Gane, et al.
Pageof 46